Skip to main content
Chabiotech Co.,Ltd. logo

Chabiotech Co.,Ltd. — Investor Relations & Filings

Ticker · 085660 ISIN · KR7085660009 KO Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2020-02-27 Management Reports
Country KR South Korea
Listing KO 085660

About Chabiotech Co.,Ltd.

http://en.chabio.com/

Chabiotech Co., Ltd. is a biotechnology company specializing in the research and development of cell and gene therapies for rare cancers and incurable diseases. The company's core activities include advancing its therapeutic pipelines and providing global Contract Development and Manufacturing Organization (CDMO) services for advanced biopharmaceuticals, including full-scale GMP production and testing. Chabiotech also operates bio-banking services, such as cord blood and immune/stem cell storage, utilizing advanced cryopreservation technology. Its diversified business segments extend to genomics for precision medicine, healthcare IT solutions that integrate AI and Big Data, comprehensive wellness programs, and specialized healthcare consulting.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 95% confidence The document is a regulatory filing from a Korean company (Cha Biotech) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (DART system) for material financial changes. Since it provides the initial financial highlights and reasons for the change before the final audit is completed, it falls under the 'Earnings Release' category as it serves the purpose of announcing periodic financial results and key performance indicators.
2020-02-27 Korean
기타경영사항(특허권취득)(자율공시)(향상된 탯줄유래 부착형 줄기세포, 그 제조방법 및 그 용도)
Regulatory Filings Classification · 95% confidence The document is a regulatory disclosure regarding the acquisition of a patent by Cha Biotech. It details the patent name, content, and strategic utilization plan. Since it does not fit into specific categories like financial reports, management changes, or shareholder communications, it falls under the general regulatory filing category.
2020-01-15 Korean
기업설명회(IR)개최
Investor Presentation Classification · 95% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (Non-Deal Road Show). It provides details such as the date, location, purpose, and target audience for the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement regarding company activities, it is classified as a Regulatory Filing (RNS).
2019-11-26 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Cha Biotech' (차바이오텍) covering the period from January 1, 2019, to September 30, 2019. It contains detailed financial information, company overview, history, and capital changes, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-14 Korean
기타경영사항(특허권취득)(자율공시)(폐암세포의 분리 및 부유배양 기법을 이용한 증식)
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by CHA Biotech. It details the patent name, content, and application plan. Since this is a specific corporate announcement regarding a business development (patent acquisition) that does not fit into financial reporting, dividend, or management change categories, it falls under the general regulatory filing category.
2019-11-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including specific transaction dates, methods (e.g., open market sales), and the resulting changes in shareholding percentages. This falls under the category of Major Shareholding Notification.
2019-10-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.